MoneyWorks4Me

Cipla board to consider unaudited financial results

26 Oct 2012 Evaluate
Cipla has informed that a meeting of the board of directors of the company will be held on November 05, 2012, to consider unaudited financial results for second quarter ended September 30, 2012 (Q2).

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1847.35
Dr. Reddys Labs. 1221.25
Cipla 1384.65
Lupin 2063.90
Zydus Lifesciences 1211.50
View more..